Exploring GLP-1 Medications in Rheumatology

This chapter examines a retrospective study on the effects of anti-obesity medications, semaglutide and terizapatide, in patients with rheumatoid arthritis. It highlights both the benefits and challenges associated with these treatments, including gastrointestinal side effects and access issues that lead to discontinuation. Additionally, the discussion covers the potential anti-inflammatory properties of GLP-1 medications and the evolving role of exercise in managing conditions like Takayasu arteritis.